COMPLETED

Drawing and Anxiety Study

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

Anxiety is among the most common emotional difficulties impacting well-being, highlighting the need for approachable anxiety-reduction tools. Both mindfulness and art-based interventions have been shown to decrease anxiety symptoms. These studies integrate these approaches via a novel guided drawing intervention, and tests effects on anxiety (pre/post drawing and at one-week follow-up) and physiological regulation (respiratory sinus arrhythmia). This registration includes two separate intervention studies with similar protocols but using different samples - one consisting of adolescents ages 13 to 17.9 years, and the other consisting of adults ages 18 to 25 years. Participants complete a laboratory visit during which they complete questionnaires about their emotions and anxiety, complete pre/post measures of cardiac physiology and state anxiety, and engage in a drawing session. Participants also complete a one-week follow-up self-report of anxiety symptoms. The intervention protocol is briefly described as follows: participants in each sample are randomly assigned to one of three groups (guided drawing, free drawing control, or basic control).

Official Title

Drawing and Anxiety Study: Investigation of a Guided-Drawing and Mindfulness Intervention to Reduce Anxiety

Quick Facts

Study Start:2022-09-29
Study Completion:2025-06-30
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:COMPLETED

Study ID

NCT06838351

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:13 Years to 25 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:CHILD, ADULT
Inclusion CriteriaExclusion Criteria
  1. * Within the specified age range (13 to 17.9 years for adolescent version; 18 to 25 years for adult version)
  2. * Able to speak, read and understand English
  1. * Outside the specified age range (13 to 17.9 years for adolescent version; 18 to 25 years for adult version)
  2. * Not able to speak, read and understand English

Contacts and Locations

Principal Investigator

Sarah Myruski, PhD
PRINCIPAL_INVESTIGATOR
The Pennsylvania State University

Study Locations (Sites)

Penn State University
University Park, Pennsylvania, 16802
United States

Collaborators and Investigators

Sponsor: Penn State University

  • Sarah Myruski, PhD, PRINCIPAL_INVESTIGATOR, The Pennsylvania State University

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2022-09-29
Study Completion Date2025-06-30

Study Record Updates

Study Start Date2022-09-29
Study Completion Date2025-06-30

Terms related to this study

Keywords Provided by Researchers

  • anxiety
  • mindfulness
  • drawing
  • RSA

Additional Relevant MeSH Terms

  • Anxiety